全文获取类型
收费全文 | 1422997篇 |
免费 | 116846篇 |
国内免费 | 3388篇 |
专业分类
耳鼻咽喉 | 18473篇 |
儿科学 | 47030篇 |
妇产科学 | 41531篇 |
基础医学 | 202852篇 |
口腔科学 | 37942篇 |
临床医学 | 127680篇 |
内科学 | 286911篇 |
皮肤病学 | 33792篇 |
神经病学 | 118386篇 |
特种医学 | 54270篇 |
外国民族医学 | 464篇 |
外科学 | 212077篇 |
综合类 | 32846篇 |
现状与发展 | 3篇 |
一般理论 | 494篇 |
预防医学 | 111518篇 |
眼科学 | 31853篇 |
药学 | 99377篇 |
1篇 | |
中国医学 | 3365篇 |
肿瘤学 | 82366篇 |
出版年
2021年 | 11420篇 |
2019年 | 12163篇 |
2018年 | 17222篇 |
2017年 | 13107篇 |
2016年 | 14800篇 |
2015年 | 16562篇 |
2014年 | 23274篇 |
2013年 | 34348篇 |
2012年 | 46790篇 |
2011年 | 49311篇 |
2010年 | 28855篇 |
2009年 | 27718篇 |
2008年 | 45325篇 |
2007年 | 47869篇 |
2006年 | 48282篇 |
2005年 | 46669篇 |
2004年 | 44467篇 |
2003年 | 42340篇 |
2002年 | 40810篇 |
2001年 | 73073篇 |
2000年 | 74571篇 |
1999年 | 61623篇 |
1998年 | 17083篇 |
1997年 | 15524篇 |
1996年 | 15636篇 |
1995年 | 14833篇 |
1994年 | 13438篇 |
1993年 | 12630篇 |
1992年 | 45868篇 |
1991年 | 43499篇 |
1990年 | 41505篇 |
1989年 | 39565篇 |
1988年 | 36185篇 |
1987年 | 35358篇 |
1986年 | 32875篇 |
1985年 | 31290篇 |
1984年 | 23841篇 |
1983年 | 20038篇 |
1982年 | 12226篇 |
1981年 | 10791篇 |
1979年 | 20707篇 |
1978年 | 14586篇 |
1977年 | 12092篇 |
1976年 | 11369篇 |
1975年 | 11623篇 |
1974年 | 13990篇 |
1973年 | 13539篇 |
1972年 | 12639篇 |
1971年 | 11477篇 |
1970年 | 10914篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
221.
222.
Susan C. Fox Jane A. May Natalia Dovlatova Jackie R. Glenn Andrew Johnson Ann E. White 《Platelets》2019,30(3):290-295
Measurement of P-selectin on activated platelets as a means of measuring platelet function utilizing the technology described here has the advantage of not requiring immediate access to specialist equipment and expertise. Blood samples are activated, fixed, stored, and transported to a central laboratory for flow cytometric analysis. Here we have compared P-selectin with other more traditional approaches to measuring platelet function in blood and/or platelet-rich plasma (PRP) from patients with acute coronary syndromes on treatment for at least 1 month with either aspirin and clopidogrel or aspirin with prasugrel. The comparators were light transmission aggregometry (LTA), VerifyNow and Multiplate aggregometry (for determining the effects of aspirin) and LTA, VerifyNow and Multiplate together with the BioCytex VASP phosphorylation assay (for the P2Y12 antagonists). The P-selectin Aspirin Test revealed substantial inhibition of platelet function in all but three of 96 patients receiving aspirin with clopidogrel and in none of 51 patients receiving aspirin and prasugrel. The results were very similar to those obtained using LTA. There was only one patient with high residual platelet aggregation and low P-selectin expression. The same patients identified as “non-responders” to aspirin also presented with the highest residual platelet activity as measured using the VerifyNow system, although not quite as well separated from the other values. With the Multiplate test only one of these patients clearly stood out from the others. The results obtained using the P-selectin P2Y12 Test in 102 patients taking aspirin and clopidogrel were similar to the more traditional approaches in that a wide scatter of results was obtained. Generally, high values seen with the P-selectin P2Y12 Test were also high with the LTA, VerifyNow, Multiplate, and BioCytex VASP P2Y12 Tests. Similarly, low residual platelet function using the P2Y12 test was seen irrespective of the testing procedure used. However, there were differences in some patients. Prasugrel was always more effective than clopidogrel in inhibiting platelet function with none of 56 patients (P-selectin and VerifyNow), only 2 of 56 patients (Multiplate) and only 3 of 56 patients (Biocytex VASP) demonstrating high on-treatment residual platelet reactivity (HRPR) defined using previously published cut-off values. The exception was LTA where there were 11 of 56 patients with HRPR. It remains to be seen which experimental approach provides the most useful information regarding outcomes after adjusting therapies in treated patients. 相似文献
223.
224.
Growth Hormone Induces Recurrence of Infantile Hemangiomas After Apparent Involution: Evidence of Growth Hormone Receptors in Infantile Hemangioma
下载免费PDF全文
![点击此处可从《Pediatric dermatology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Naikhoba C. O. Munabi B.A. Qian Kun Tan H.S. Maria C. Garzon M.D. Gerald G. Behr M.D. Carrie J. Shawber Ph.D. June K. Wu M.D. 《Pediatric dermatology》2015,32(4):539-543
Infantile hemangiomas (IHs) are the most common benign tumor of infancy, characterized by a natural history of early proliferation in the first months of life to eventual involution during childhood, often with residual fibrofatty tissue. Once involution has been achieved, IHs do not typically recur. We present two cases of exogenous growth hormone therapy resulting in the recurrence of IHs in late childhood, supported by radiological, immunohistochemical, in vitro, and in vivo evidence. 相似文献
225.
226.
227.
228.
229.
Miguel A. Sanz Pau Montesinos Haesook T. Kim Guillermo J. Ruiz-Argüelles María S. Undurraga María R. Uriarte Lem Martínez Rafael H. Jacomo Homero Gutiérrez-Aguirre Raul A. M. Melo Rosane Bittencourt Ricardo Pasquini Katia Pagnano Evandro M. Fagundes Edo Vellenga Alexandra Holowiecka Ana J. González-Huerta Pascual Fernández Javier De la Serna Salut Brunet Elena De Lisa José González-Campos José M. Ribera Isabel Krsnik Arnold Ganser Nancy Berliner Raul C. Ribeiro Francesco Lo-Coco Bob L?wenberg Eduardo M. Rego 《Annals of hematology》2015,94(8):1347-1356
230.
Roberto V.P. Ribeiro Mitesh V. Badiwala Danny Ramzy Laura C. Tumiati Vivek Rao 《The Journal of thoracic and cardiovascular surgery》2019,157(2):615-625.e1